Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

No comments

Register to receive a free Small Bone and Joint Orthopedic Devices Market Report Suite for US synopsis and brochure

Shoulder Innovations announced that they have received FDA clearance for their InSet Humeral Short Stem System.  This is a key addition to their expanding shoulder portfolio and another milestone for their vision to offer a complete leading technology shoulder arthroplasty product line.

The clearance covers products used for partial or total shoulder arthroplasty used in the treatment of degenerative, rheumatoid or traumatic arthritis in the shoulder.  The new InSet Shoulder system provides innovative features and solutions to address potential problems encountered with current total shoulder replacement systems.

Peter Johnston, M.D. of Southern Maryland Orthopaedic and Sports Medicine said, “The strengths of the InSet Shoulder System are its streamlined instrumentation, proprietary coating technology for implant fixation with bone preservation and ability to reproduce native humeral anatomy.  The system is game-changing.”

Robert Tashjian, M.D. of the University of Utah added, “The combination of the InSet Humeral Stem and Shoulder Innovation’s unique InSet glenoid implant affords a surgically simple, bone sparing option for many types of humeral or glenoid deformities associated with arthritis.”

Rob Ball, Executive Chairman of Shoulder Innovations said, “We are excited to see the fast-paced progress and results made by the team. Genesis Innovation Group has moved rapidly in developing this highly innovative new product line.  It plays a pivotal role in the Shoulder Innovations strategy, and Genesis has proven to be an excellent partner in helping our company move forward.”

Shoulder Innovations has also recently announced new investments that will be used to fuel new product development, and to acquire inventory and assets to accelerate growth of its current InSet platform technology.  This technology serves as a foundational platform on which many future products and systems are in development.

The long-term vision of Shoulder Innovations is to offer a complete leading technology shoulder arthroplasty product line.

Source: https://www.prnewswire.com/news-releases/shoulder-innovations-announces-fda-510k-clearance-for-shoulder-technology-300743430.html

For Further Information

More on the small bone and joint orthopedic devices market in the U.S. can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Small Bone and Joint Orthopedic Devices. This report covers the following market segments: shoulder reconstruction devices, elbow repair devices, hand & wrist devices, foot & ankle devices, plate & screw devices, staple fixation devices and external fixation devices.

The iData series on the market for small bone and joint orthopedic devices covers the U.S., India, Japan, and China. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about small bone and joint orthopedic devices market data or procedure data, register online or email us at [email protected] for an U.S. Market Report Suite for Small Bone and Joint Orthopedic Devices brochure and synopsis.

iData ResearchShoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

Related Posts